[1] Ding,D,Zhou,D,Sander,JW,et al.Epilepsy in China:major progress in the past two decades [J].LANCET NEUROL,2021,20 (4):316~326. [2] Increase in Epilepsy Cases [J].Jama-J am Med Assoc,2017,318 (12):1100. [3] Gómez CD,Buijs RM,Sitges M.The anti-seizure drugs vinpocetine and carbamazepine,but not valproic acid,reduce inflammatory IL-1β and TNF-α expression in rat hippocampus [J].J Neurochem,2014,130(6):770~779. [4] Fukuda M,Hino H,Suzuki Y,et al.Postnatal interleukin-1β enhances adulthood seizure susceptibility and neuronal cell death after prolonged experimental febrile seizures in infantile rats[J].Acta Neurol Belg,2014,114(3):179~185. [5] Kebede TG,Dube S,Nindi MM.Removal of non-steroidal anti-inflammatory drugs (NSAIDs) and carbamazepine from wastewater using water-soluble protein extracted from Moringa stenopetala seeds [J].J Environ Chem Eng,2018,6(2):3095~3103. [6] Sumadewi KT,Harkitasari S,Tjandra DC.Biomolecular mechanisms of epileptic seizures and epilepsy:a review[J].Acta Epileptol,2023,5 (1):28. [7] Mukhtar I.Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy:From pathogenesis to treatment target[J].Seizure,2020,82:65~79. [8] Pottoo FH,Salahuddin M,Khan FA,et al.Combinatorial regimen of carbamazepine and imipramine exhibits synergism against grandmal epilepsy in rats:inhibition of pro-Inflammatory cytokines and PI3K/Akt/mTOR signaling pathway[J].Pharmaceuticals (Basel),2021,14 (11):1204. [9] Rana A,Musto AE.The role of inflammation in the development of epilepsy[J].J Neuroinflammation,2018,15 (1):144. [10] Salimi A,Sabetkasaei M,Raisi H,et al.Carbamazepine effects on pain management and serum IL-6,IL-10 evaluation in addicted patients undergoing surgery[J].Eur J Pharmacol,2017,812:184~188. [11] Vande Walle L,Lamkanfi M.Pyroptosis[J].Curr Biol,2016,26(13):R568~R72. [12] Weinlich R,Oberst A,Beere HM,Green DR.Necroptosis in development,inflammation and disease[J].Nat Rev Mol Cell Biol,2017,18(2):127~136. [13] Tan CC,Zhang JG,Tan MS,et al.NLRP1 inflammasome is activated in patients with medial temporal lobe epilepsy and contributes to neuronal pyroptosis in amygdala kindling-induced rat model[J].J Neuroinflammation,2015,12(1):18. [14] Meng XF,Tan L,Tan MS,et al.Inhibition of the NLRP3 inflammasome provides neuroprotection in rats following amygdala kindling-induced status epilepticus[J].J Neuroinflammation,2014,11(1):212. [15] Shi XY,Sun QC,Hou YJ,et al.Recognition and maturation of IL-18 by caspase-4 noncanonical inflammasome[J].Nature,2023,624 (7991):442~450. [16] Scharfman HE.The dentate gyrus and temporal lobe epilepsy:an “exciting” era[J].Epilepsy Curr,2019,19(4):249~255. [17] 牛晓军,陈靖京,王明正,等.卡马西平对青霉素点燃癫痫大鼠脑内GABAB受体蛋白表达的影响[J].中国药物与临床,2009,9(4):294~297. [18] Chen SY,Zeng XC,Zong WJ,et al.Aucubin Alleviates Seizures Activity in Li-Pilocarpine-Induced Epileptic Mice:Involvement of Inhibition of Neuroinflammation and Regulation of Neurotransmission[J].Neurochem Res,2019,44(2):472~484. [19] Pitkänen A,Buckmaster P,Galanopoulou AS,et al.Models of seizures and epilepsy[M].2nd ed.Academic Press,2017. [20] Yang P,Qin Y,Zhu Y,et al.Chaihu-Longgu-Muli decoction relieves epileptic symptoms by improving autophagy in hippocampal neurons[J].J Ethnopharmacol,2020,259:112990. [21] Yan Raowei,Zhang Hesheng,洪震,等.钠离子通道阻滞剂药物治疗局灶性癫痫的中国专家应用共识[J].癫痫杂志,2025,11(5):430~441. [22] 谭莎莎.卡马西平相关抗癫痫药物治疗癫痫的研究进展[J].医学理论与实践,2023,36(16):2730~2732+2735. [23] Rana A,Musto AE.The role of inflammation in the development of epilepsy[J].Journal of Neuroinflammation,2018,15(1):144. [24] Quirico-Santos T,Meira ID,Gomes AC,Pereira VC,Pinto M,Monteiro M,et al.Resection of the epileptogenic lesion abolishes seizures and reduces inflammatory cytokines of patients with temporal lobe epilepsy[J].Journal of Neuroimmunology.2013;254(1-2):125~130. [25] Schroder K,Tschopp J.The Inflammasomes[J].Cell.2010,140(6):821~832. [26] Den Hartigh AB,Fink SL.Pyroptosis induction and detection[J].CP Immunology,2018,122(2):e52. [27] Ye Z,Li Q,Guo QL,et al.Ketamine induces hippocampal apoptosis through a mechanism associated with the caspase-1 dependent pyroptosis[J].Neuropharmacology,2018,128:63~75. [28] Zhan XY,Li Q,Xu G,et al.The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors[J].Front Immunol,2023,13:1109938. [29] Swanson KV,Deng M,Ting JP.The NLRP3 inflammasome:molecular activation and regulation to therapeutics[J].Nat Rev Immunol,2019,19(8):477~489. [30] Song N,Liu ZS,Xue W,et al.NLRP3 phosphorylation is an essential priming event for inflammasome activation[J].Mol Cell,2017,68(1):185~197. [31] Wang ZL,Xu G,Zhan X,et al.Carbamazepine promotes specific stimuli-induced NLRP3 inflammasome activation and causes idiosyncratic liver injury in mice[J].Arch Toxicol,2019,93(12):3585~3599. [32] Yang XX,Cao QQ,Guo Y,et al.GSDMD knockdown attenuates phagocytic activity of microglia and exacerbates seizure susceptibility in TLE mice[J].J Neuroinflammation.2023,20(1):193. [33] Sun WW,Hao Y,Li CX,et al.Inhibition of galectin-3 in a rat model of epilepsy and kainate-activated BV2 cells limits microglial activation through the NLRP3/pyroptosis pathway[J].Neuroimmunomodulation,2023,30(1):325~337. [34] Zhang,SH,Chen,F,Zhai,F,et al.Role of HMGB1/TLR4 and IL-1β/IL-1R1 signaling pathways in Epilepsy[J].Front Neurol,2022:13 904225. |